Avery developed osteoporosis after taking Ozempic for about a year without a doctor's supervision. She originally sought the ...

Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...

Biosimilars have also made inroads among generic suppliers. But development is lengthy and expensive. McKinsey estimates that it costs $100 to $300 million to develop a biosimilar and that it takes ...

The FDA approved the denosumab biosimilar Ospomyv, interchangeable with Prolia, for preventing osteoporosis-related fracture ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

Six percent of Americans have used Ozempic, Wegovy and similar drugs. They’re unwitting experimental subjects.